The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
ISPT03b - Discover the Impact of GEMTESA® (Vibegron) 75mg Tablets, An Effective OAB Treatment: A Fresh Look at OAB Management in Long-Term Care Settings (Sponsored by Urovant Sciences)
Lunch will be provided. Attendees will be admitted on a first-come basis.
Supported by Urovant Sciences.
This presentation theater discusses the clinical profile and prescribing information for GEMTESA® for the treatment of overactive bladder. The presentation also reviews challenges associated with overactive bladder in long-term care.
Qung Yang
4/27/22 2:50 pm
she is a good speaker, the topic is very practical.